GlassScriptPhysician profile
Steven M Willard
NPI 1720237613
$1,023.40
in general payments reported to CMS, 2019-2025
23 companies · $90.84 in 2025
The $90.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2022: $232 · 2023: $322 · 2024: $126 · 2025: $90.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $118.99 | 2019 | |
| Abbvie INC. | $115.54 | 2022-2023 | Orilissa |
| Axonics, INC. | $112.18 | 2023-2024 | Axonics, Bulkamid |
| Hologic Sales and Service, LLC | $99.97 | 2023-2025 | Coolseal Generator, Acessa Provu System, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $68.20 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $49.11 | 2022-2023 | |
| Myovant Sciences INC. | $48.78 | 2022 | |
| Pfizer INC. | $46.24 | 2022-2023 | |
| Astellas Pharma US INC | $45.62 | 2023-2024 | Veozah |
| Avion Pharmaceuticals | $38.90 | 2019-2022 | |
| Sage Therapeutics, LLC | $37.34 | 2023-2024 | |
| Baxter Healthcare | $36.91 | 2019-2023 | Seprafilm |
| Therapeuticsmd, INC. | $29.29 | 2019 | |
| Boston Scientific Corporation | $28.98 | 2025 | Axonics |
| Exeltis, USA INC. | $28.86 | 2023-2024 | Slynd |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $18.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.67 | 2019 | |
| Lupin INC. | $15.65 | 2019 | |
| Agile Therapeutics, INC. | $14.62 | 2022 | |
| Allergan, INC. | $14.13 | 2019 | |
| Merck Sharp & Dohme LLC | $13.58 | 2023 | Gardasil 9 |
| Optumhealth Care Solutions, LLC | $13.19 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Coopersurgical, INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Willard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.